Profitable Companies in Health Care
S&P 500 companies with positive net income. These companies generated a profit over the trailing twelve months.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
55 Companies Meeting Criteria
Showing 1–50 of 55 companies, ranked by Net Income.
| # | Company | Net Income | Profit Margin |
|---|---|---|---|
| 1 | JNJJohnson & Johnson | $25.1B | 27.3% |
| 2 | MRKMerck & Co. | $19.0B | 29.6% |
| 3 | LLYLilly (Eli) | $18.4B | 31.0% |
| 4 | PFEPfizer | $9.8B | 15.7% |
| 5 | GILDGilead Sciences | $8.1B | 27.9% |
| 6 | AMGNAmgen | $7.0B | 19.5% |
| 7 | BMYBristol Myers Squibb | $6.0B | 12.6% |
| 8 | REGNRegeneron Pharmaceuticals | $4.6B | 32.1% |
| 9 | VRTXVertex Pharmaceuticals | $3.7B | 31.4% |
| 10 | ZTSZoetis | $2.7B | 28.2% |
| 11 | ABBVAbbVie | $2.4B | 4.0% |
| 12 | INBXInhibrx Biosciences, Inc. | $1.7B | - |
| 13 | BIIBBiogen | $1.6B | 16.0% |
| 14 | UTHRUnited Therapeutics | $1.3B | 40.6% |
| 15 | INCYIncyte | $1.2B | 24.7% |
| 16 | RPRXRoyalty Pharma plc | $859M | 38.0% |
| 17 | EXELExelixis | $678M | 29.6% |
| 18 | AGIOAGIOS PHARMACEUTICALS, INC. | $674M | - |
| 19 | HALOHalozyme | $595M | 47.9% |
| 20 | BMRNBioMarin Pharmaceutical | $520M | 16.8% |
| 21 | OGNOrganon & Co. | $501M | 8.0% |
| 22 | NBIXNeurocrine Biosciences | $428M | 16.0% |
| 23 | BHCBausch Health Companies Inc. | $362M | 3.6% |
| 24 | ALKSAlkermes plc | $339M | 22.3% |
| 25 | PTGXProtagonist Therapeutics, Inc. | $275M | - |
| 26 | ACADAcadia Pharmaceuticals | $261M | 24.9% |
| 27 | PBHPrestige Consumer Healthcare | $215M | 18.9% |
| 28 | ADMAADMA Biologics, Inc. | $198M | 46.4% |
| 29 | CPRXCatalyst Pharmaceuticals Partners, Inc. | $164M | 33.3% |
| 30 | AMPHAmphstar Pharmaceuticals, Inc. | $160M | 21.8% |
| 31 | HRMYHarmony Biosciences Holdings, Inc. | $145M | 20.4% |
| 32 | CORTCorcept Therapeutics Incorporated | $141M | 20.9% |
| 33 | INDVIndivior | $123M | 10.4% |
| 34 | KRYSKrystal Biotech, Inc. | $89M | 30.7% |
| 35 | EBSEmergent BioSolutions Inc. | $76M | 9.6% |
| 36 | SUPNSupernus Pharmaceuticals, Inc. | $74M | 11.2% |
| 37 | COLLCollegium Pharmaceutical, Inc. | $69M | 11.0% |
| 38 | AMRXAmneal Pharmaceuticals, Inc. | $49M | 1.7% |
| 39 | LGNDLigand Pharmaceuticals, Inc. | $49M | 19.3% |
| 40 | PAHCPhibro Animal Health | $48M | 3.7% |
| 41 | CRONCronos Group Inc. | $41M | 34.9% |
| 42 | ELANElanco | $36M | 0.8% |
| 43 | CTMXCytomX Therapeutics, Inc. | $32M | 23.1% |
| 44 | MNKDMANNKIND CORP | $28M | 9.7% |
| 45 | DVAXDynavax Technologies Corp. | $27M | 9.8% |
| 46 | INVAInnoviva, Inc. | $23M | 6.5% |
| 47 | TGTXTG Therapeutics, Inc. | $23M | 7.1% |
| 48 | PVLAPALVELLA THERAPEUTICS, INC. | $19M | 43.7% |
| 49 | GYREGYRE THERAPEUTICS, INC. | $18M | 16.9% |
| 50 | RIGLRIGEL PHARMACEUTICALS INC | $17M | 9.8% |
What Makes a Company Profitable?
A profitable company earns more revenue than it spends on expenses, taxes, and interest. Net income (the "bottom line") is the most common measure of profitability. While most S&P 500 companies are profitable, some may temporarily report losses due to restructuring, acquisitions, or cyclical downturns.
Net Income > $0
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics